e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
Thoracic oncology: from fusion genes to treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Drugs that target fusion genes
Giulio Metro (Perugia, Italy)
Source:
International Congress 2015 – Thoracic oncology: from fusion genes to treatment
Session:
Thoracic oncology: from fusion genes to treatment
Session type:
Symposium
Number:
1432
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Giulio Metro (Perugia, Italy). Drugs that target fusion genes. International Congress 2015 – Thoracic oncology: from fusion genes to treatment
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Targets in gene transcription
Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes
Year: 2005
Gene expression profiling: identifying novel gene targets for therapeutic intervention
Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow
Year: 2008
The KEAP1/NRF2 signaling system genes and theirs target genes are associated with COPD
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018
Management of patients with a tumoural fusion gene
Source: International Congress 2015 – Thoracic oncology: from fusion genes to treatment
Year: 2015
Evaluation of gene expression during in vitro ciliogenesis to search for novel candidate genes in primary ciliary dyskinesia
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
Targeting targeted therapies: more choices and the best sequences
Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer
Year: 2018
Study of gene expression control elements of the human SP-A genes: Role of the 5‘UTR exon B
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
Searching for suceptibility genes: Association studies
Source: Research Seminar 2004 - Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases
Year: 2004
Investigation for candidate genes of glucocorticoid resistance by genome-wide gene expression profiling in animal model of asthma
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011
Late Breaking Abstract - Differentially expressed exosomal miRNAs target key inflammatory pathways in COPD.
Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Year: 2018
Biomarkers of lung cancer based on the expression of genes, transposons and repetitive elements
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020
In silico analysis of tuberculosis and multiple sclerosis gene expression profiles reveals coregulated genes implicated in host response to pathogens.
Source: International Congress 2017 – Human susceptibility to tuberculosis
Year: 2017
Candidate surrogate markers for COPD identified by differential gene expression
Source: Eur Respir J 2002; 20: Suppl. 38, 583s
Year: 2002
Distinct BARD1 isoforms expressed in lung cancer potential targets for treatment
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008
Oral presentation: Truncated isoforms of BRCA1-associated protein BARD1 are expressed in NSCLC and are potential targets for treatment
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009
Expression of a novel regulatory ORF from the β2 adrenoceptor gene locus in human bronchoepithelial cell line
Source: Eur Respir J 2002; 20: Suppl. 38, 92s
Year: 2002
Mutations in the retinoblastoma-related gene RB2/p130 in lung tumours and suppression of tumour growth
in vivo
by retrovirus-mediated gene transfer
Source: Annual Congress 2002 - Thoracic oncology: biology
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept